KSA Self-Monitoring Blood Glucose Devices Market Outlook to 2028

KSA Self- Monitoring Blood Glucose Devices Market Overview

The KSA Self- Monitoring Blood Glucose Devices Market was valued at USD 115 million, driven by the increasing prevalence of diabetes, particularly Type 2 diabetes, which affects a significant portion of the Saudi population. The high prevalence of obesity, sedentary lifestyles, and consumption of high-calorie diets are key factors behind this growing demand for self-monitoring devices.

In the Saudi market, dominant cities such as Riyadh and Jeddah play a crucial role due to their advanced healthcare infrastructure and access to cutting-edge medical technology. The high concentration of healthcare facilities and diabetes care centers in these cities, along with greater healthcare spending and consumer awareness, contributes to their leadership in this market.

The Ministry of Health plans to provide subsidized or free self-monitoring blood glucose devices to over 500,000 low-income diabetic patients in 2024 as part of its chronic disease management initiative. This policy will improve the accessibility of essential diabetes management tools for economically disadvantaged groups.

KSA Self- Monitoring Blood Glucose Devices Market Segmentation

By Product Type: The market is segmented by product type into Glucometer Devices, Test Strips, and Lancets. Among these, glucometer devices hold the largest share of the market. The convenience of real-time monitoring, portability, and technological advancements like Bluetooth connectivity make glucometers a popular choice among diabetics. Moreover, the preference for home-based monitoring and user-friendly interfaces provided by glucometers have driven their demand.

By End- User: The market for self-monitoring devices is also segmented by end-user into Hospitals, Homecare, and Clinics. Homecare dominates this segment due to the increasing trend of home-based diabetes management. With rising healthcare costs and the development of user-friendly self-monitoring devices, more patients prefer to manage their condition at home. The availability of affordable devices and remote monitoring solutions is also boosting this trend.

KSA Self- Monitoring Blood Glucose Devices Market Competitive Landscape

The market is moderately consolidated, with a few key global players dominating the market. Leading companies are focused on innovative products, strategic collaborations, and enhancing distribution networks to capture a larger market share.

Company Name

Establishment Year

Headquarters

Revenue (USD Bn)

No. of Employees

Key Products

R&D Investment

Global Presence

Recent Developments

Roche Diabetes Care

1896

Basel, Switzerland

Abbott Diabetes Care

1888

Illinois, USA

Ascensia Diabetes Care

2016

Basel, Switzerland

Life Scan

1981

California, USA

Arkray

1960

Kyoto, Japan

KSA Self- Monitoring Blood Glucose Devices Market Analysis

Market Growth Drivers

Rising Diabetes Prevalence: The number of people with diabetes in Saudi Arabia is projected to surpass 4.5 million in 2024, contributing to increased demand for self-monitoring blood glucose devices. The significant rise in diabetes-related hospital admissions, projected to reach over 100,000 annually, highlights the growing need for accessible glucose monitoring solutions, particularly in rural areas where diabetes management remains challenging.

Increased Government Health Expenditure: The Saudi government is expected to allocate over SAR 200 billion toward healthcare in 2024, with a portion aimed at managing chronic conditions like diabetes. This increase in funding directly supports the adoption of self-monitoring blood glucose devices, as the governments initiative includes expanding healthcare access and improving chronic disease management through subsidies and public health programs.

Growing Geriatric Population: The elderly population in Saudi Arabia is expected to reach 5 million by 2024, a group particularly vulnerable to diabetes and related health complications. As a result, self-monitoring blood glucose devices are becoming increasingly essential to daily care routines. The Ministry of Health is focusing on specialized healthcare programs for seniors, driving the demand for glucose monitoring devices in clinics and home-care settings.

Market Challenges

Limited Healthcare Infrastructure in Remote Regions: While urban areas like Riyadh and Jeddah have well-developed healthcare infrastructures, remote regions with populations exceeding 2 million still struggle with access to diabetes care services. The lack of specialized healthcare professionals and diabetes educators further complicates the adoption and regular use of blood glucose monitoring devices, hindering market expansion.

Complicated Reimbursement Processes: Although insurance coverage has expanded, the reimbursement process for self-monitoring blood glucose devices can be lengthy and complex, especially for lower-income groups. An estimated 30% of patients report difficulties in navigating reimbursement channels, delaying their access to essential monitoring devices, which continues to challenge the smooth growth of the market.

KSA Self- Monitoring Blood Glucose Devices Market Future Outlook

Over the next five years, the KSA Self- Monitoring Blood Glucose Devices industry is expected to experience growth. This is due to a combination of factors including increased government support, continued advancements in glucose monitoring technology, and rising consumer awareness of managing diabetes through self-monitoring.

Future Market Opportunities

Increased Adoption of AI-Driven Monitoring: Over the next five years, AI-driven glucose monitoring devices will become a market standard in Saudi Arabia. By 2029, it is estimated that over 500,000 AI-powered devices will be in use, providing personalized insights into glucose levels and supporting more precise diabetes management.

Expansion of Telemedicine Integration: The integration of self-monitoring blood glucose devices with telemedicine platforms will increase, reaching over 1.5 million users by 2029. This growth will be driven by the need for continuous, remote monitoring of chronic diseases, supported by government-backed telemedicine expansion programs.
Please Note: It will take 5-7 business days to complete the report upon order confirmation